Aldeyra is set to resume trading at 4:35 pm ET, with quotation scheduled to resume at 4:30 pm ET, according to Nasdaq. The stock had been halted, news pending, ahead of the company announcing receipt of a Complete Response Letter from the FDA for the New Drug Application of reproxalap, an investigational drug candidate, for the treatment of dry eye disease.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALDX:
